Contact dermatitis is a common dermatologic condition that can cause significant impairment in patients’ overall quality of life (QoL). This impact is separate and potentially more clinically relevant than one’s disease “severity” in contact dermatitis and should be consistently addressed by dermatologists. Despite this, QoL tools specific to contact dermatitis are lacking, and there is little consistency in the literature regarding the tool used to evaluate clinical response to therapies. Measurements currently available to evaluate disease-related QoL in contact dermatitis fit into 1 of the following 3 general types: generic health-related QoL measures, dermatology-related QoL measures, or specific dermatologic disease–related QoL measures. This article reviews the strengths and weaknesses of existing QoL tools used in contact dermatitis including: Short Form Survey 36, Dermatology Life Quality Index, Skindex-29, Skindex-16, Dermatology-Specific Quality of Life, and Fragrance Quality of Life Index.
Get full access to this article
View all access options for this article.
References
1.
ThyssenJP, JohansenJD, LinnebergA, et al.The epidemiology of hand eczema in the general population—prevalence and main findings. Contact Dermatitis, 2010; 62:75–87.
2.
BourkeJ, CoulsonI, EnglishJ. Guidelines for care of contact dermatitis. Br J Dermatol, 2001; 145:877–885.
3.
AndersonRT, RajagopalanR. Effects of allergic dermatosis on health-related quality of life. Curr Allergy Asthma Rep, 2001; 1:309–315.
4.
AyalaF, NinoM, FabbrociniG, et al.Quality of life and contact dermatitis: a disease-specific questionnaire. Dermatitis, 2010; 21:84–90.
5.
WooPN, HayIC, OrmerodAD. An audit of the value of patch testing and its effect on quality of life. Contact Dermatitis, 2003; 48:244–247.
6.
HutchingsCV, ShumKW, GawkrodgerDJ. Occupational contact dermatitis has an appreciable impact on quality of life. Contact Dermatitis, 2001; 45:17–20.
7.
LauMY, BurgessJA, NixonR, et al.A review of the impact of occupational contact dermatitis on quality of life. J Allergy (Cairo), 2011; 2011:964509.
8.
HeisterbergMV, MennéT, JohansenJD. Fragrance allergy and quality of life - development and validation of a disease-specific quality of life instrument. Contact Dermatitis, 2014; 70:69–80.
9.
SkoetR, ZachariaeR, AgnerT. Contact dermatitis and quality of life: a structured review of the literature. Br J Dermatol, 2003; 149:452–456.
10.
ThomsonKF, WilkinsonSM, SommerS, et al.Eczema: quality of life by body site and the effect of patch testing. Br J Dermatol, 2002; 146:627–630.
11.
KadykDL, MccarterK, AchenF, et al.Quality of life in patients with allergic contact dermatitis. J Am Acad Dermatol, 2003; 49:1037–1048.
12.
HolnessDL, BeatonD, HarnimanE, et al.Hand and upper extremity function in workers with hand dermatitis. Dermatitis, 2013; 24:131–136.
13.
AndersonRT, RajagopalanR. Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol, 1997; 37:41–50.
14.
RehalB, ArmstrongAW. Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985–2010. PLoS One, 2011; 6:e17520.
15.
CurrN, MathesonMC, DharmageS, et al.Does the Occupational Contact Dermatitis Disease Severity Index correlate with quality of life in patients with occupational contact dermatitis of the hands?. Contact Dermatitis, 2010; 62:251–252.
16.
MaksimovicN, JankovicS, MarinkovicJ, et al.Health-related quality of life in patients with atopic dermatitis. J Dermatol, 2012; 39:42–47.
17.
BoehmD, Schmid-OttG, FinkeldeyF, et al.Anxiety, depression and impaired health-related quality of life in patients with occupational hand eczema. Contact Dermatitis, 2012; 67:184–192.
18.
FowlerJF, GhoshA, SungJ, et al.Impact of chronic hand dermatitis on quality of life, work productivity, activity impairment, and medical costs. J Am Acad Dermatol, 2006; 54:448–457.
19.
BothH, Essink-BotML, BusschbachJ, et al.Critical review of generic and dermatology-specific health-related quality of life instruments. J Invest Dermatol, 2007; 127:2726–2739.
20.
MckennaSP, CookSA, WhalleyD, et al.Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. Br J Dermatol, 2003; 149:323–331.
21.
WhalleyD, MckennaSP, DewarAL, et al.A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD). Br J Dermatol, 2004; 150:274–283.
22.
YazdanyJ. Health-related quality of life measurement in adult systemic lupus erythematosus: Lupus Quality of Life (LupusQoL), Systemic Lupus Erythematosus-Specific Quality of Life Questionnaire (SLEQOL), and Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL). Arthritis Care Res (Hoboken), 2011; 63(Suppl 11):S413–S419.
23.
DreyfusI, TaiebC, BarbarotS, et al.IQoL-32: a new ichthyosis-specific measure of quality of life. J Am Acad Dermatol, 2013; 69:82–87.
24.
StreinerD, NormanG, CairneyJ. Health Measurement Scales: A Practical Guide to Their Development and Use. 5th ed. Oxford: Oxford University Press;. 2015.
25.
SchmittJ, LanganS, WilliamsHC. What are the best outcome measurements for atopic eczema? A systematic review. J Allergy Clin Immunol, 2007; 120:1389–1398.
26.
ChenSC. Dermatology quality of life instruments: sorting out the quagmire. J Invest Dermatol, 2007; 127:2695–2696.
27.
HolnessDL. Results of a quality of life questionnaire in a patch test clinic population. Contact Dermatitis, 2001; 44:80–84.
28.
MacanJ, RimacD, KezicS, et al.Occupational and non-occupational allergic contact dermatitis: a follow-up study. Dermatology, 2013; 227:321–329.
29.
NoiesenE, MunkMD, LarsenK, et al.Difficulties in avoiding exposure to allergens in cosmetics. Contact Dermatitis, 2007; 57:105–109.
30.
LohrKN, AaronsonNK, AlonsoJ, et al.Evaluating quality-of-life and health status instruments: development of scientific review criteria. Clin Ther, 1996; 18:979–992.
31.
WareJE Jr. SF-36 health survey update. Spine (Phila Pa 1976), 2000; 25:3130–3139.
32.
WareJE Jr, SherbourneCD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care, 1992; 30:473–483.
33.
FinlayAY, KhanGK. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol, 1994; 19:210–216.
34.
LewisV, FinlayAY. 10 years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc, 2004; 9:169–180.
35.
ReillyMC, LavinPT, KahlerKH, et al.Validation of the Dermatology Life Quality Index and the Work Productivity and Activity Impairment-Chronic Hand Dermatitis questionnaire in chronic hand dermatitis. J Am Acad Dermatol, 2003; 48:128–130.
36.
ChrenMM, LasekRJ, SahayAP, et al.Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg, 2001; 5:105–110.
37.
RogersA, DelongLK, ChenSC. Clinical meaning in skin-specific quality of life instruments: a comparison of the Dermatology Life Quality Index and Skindex banding systems. Dermatol Clin, 2012; 30:333–342.
38.
ChrenMM. The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin, 2012; 30:231–236.
39.
WallenhammarLM, NyfjallM, LindbergM, et al.Health-related quality of life and hand eczema—a comparison of two instruments, including factor analysis. J Invest Dermatol, 2004; 122:1381–1389.
40.
BrazierJE, HarperR, JonesNM, et al.Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ, 1992; 305:160–164.
41.
BasraMK, FenechR, GattRM, et al.The Dermatology Life Quality Index 1994–2007: a comprehensive review of validation data and clinical results. Br J Dermatol, 2008; 159:997–1035.
42.
BasraMK, SalekMS, CamilleriL, et al.Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data. Dermatology, 2015; 230:27–33.
43.
HongboY, ThomasCL, HarrisonMA, et al.Translating the science of quality of life into practice: what do dermatology life quality index scores mean?. J Invest Dermatol, 2005; 125:659–664.
44.
ChrenMM, LasekRJ, QuinnLM, et al.Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol, 1996; 107:707–713.
45.
AbeniD, PicardiA, PasquiniP, et al.Further evidence of the validity and reliability of the Skindex-29: an Italian study on 2,242 dermatological outpatients. Dermatology, 2002; 204:43–49.
46.
MatterneU, ApfelbacherCJ, SoderS, et al.Health-related quality of life in health care workers with work-related skin diseases. Contact Dermatitis, 2009; 61:145–151.
47.
RajagopalanR, AndersonRT, SarmaS, et al.An economic evaluation of patch testing in the diagnosis and management of allergic contact dermatitis. Am J Contact Dermat, 1998; 9:149–154.
48.
RajagopalanR, AndersonRT, SarmaS, et al.The use of decision-analytical modelling in economic evaluation of patch testing in allergic contact dermatitis. Pharmacoeconomics, 1998; 14:79–95.
49.
RajagopalanR, AndersonR. Impact of patch testing on dermatology-specific quality of life in patients with allergic contact dermatitis. Am J Contact Dermat, 1997; 8:215–221.
50.
HeisterbergMV, MenneT, JohansenJD. Fragrance allergy and quality of life - a case-control study. Contact Dermatitis, 2014; 70:81–89.
